Summary of Significant Accounting Policies - Summary of Revenue (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accounting Policies [Line Items]
Revenue		$ 750,265	$ 766,554	$ 745,424
Termination payment		75,153
Contract Termination
Accounting Policies [Line Items]
Termination payment		10,000
Prescription transactions revenue
Accounting Policies [Line Items]
Revenue		550,738	550,536	593,359
Subscription revenue
Accounting Policies [Line Items]
Revenue		94,410	96,167	59,925
Pharma Manufacturer Solutions Revenue
Accounting Policies [Line Items]
Revenue	[1]	85,065	99,425	73,348
Other revenue
Accounting Policies [Line Items]
Revenue		$ 20,052	$ 20,426	$ 18,792

[1] (1)Pharma manufacturer solutions revenue for the year ended December 31, 2023 included a $10.0 million contract termination payment to a pharma manufacturer solutions client in connection with our restructuring activities, which was recognized as a reduction of revenue. See "Note 17. Restructuring Plan" for additional information.